Preventive Medicine Doctors in Maxwell Afb, AL Accepting Medicare

2 Preventive Medicine doctors found. Showing 1 - 2

Dr. Jameson Voss, M.D. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 Twining St Bldg 760, Maxwell Afb, AL 36112 Phone: 334-953-3368

Dr. David Jacob Simmons, MD Preventive Medicine - Aerospace Medicine Medicare: Medicare Enrolled Practice Location: 300 Twining St Bldg 760, 42 Mdg/sgp, Maxwell Afb, AL 36112 Phone: 334-953-3712    Fax: 334-953-8296

News Archive

Blood-circulating monocytes can replace brain resident microglia

The immune system is comprised of multiple cell types each capable of specialized functions to protect the body from invading pathogens and promote tissue repair after injury. One cell type, known as monocytes, circulates throughout the organism in the blood and enters tissues to actively phagocytose (eat!) foreign cells and assist in tissue healing.

Reid planning to start debate on COBRA, Medicaid help extensions

Senate Majority Leader Harry Reid is planning to start debate Monday on a bill that would extend COBRA health coverage benefit subsidies for people who have been laid-off. The measure, part of a larger package of expired government programs, also would help states with Medicaid reimbursements.

Health and environmental hazards of tungsten

Surprising new scientific research is raising concerns about the potential health and environmental hazards of tungsten - a metal used in products ranging from bullets to light bulbs to jewelry - that scientists once thought was environmentally-benign, according to an article scheduled for the Jan. 19 issue of Chemical & Engineering News , ACS' weekly newsmagazine.

New comic book explains to children about Primary Immunodeficiency

Primary Immunodeficiency (PID) refers to a group of disorders characterised by limited or absent function of the immune system. The majority of PIDs are inherited defects meaning that a component is either missing or does not function normally, resulting in increased susceptibility to infection. About 1 in 500 people are born with PID and doctors' estimate that approximately 5,000 people may be affected by PID in the UK.

Positive top-line results from IPX066 Phase III study in patients with PD

Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc., today announced statistically significant, positive, top-line results of the ADVANCE-Parkinson's Disease Phase III clinical study of the safety and efficacy of IPX066 versus immediate-release carbidopa-levodopa in advanced PD patients experiencing motor fluctuations.

Read more Medical News

› Verified 9 days ago